Tristel plc has a consistent record of revenue, profit and dividend growth as an AIM listed public company. It is only one of a few businesses worldwide that specialises in infection prevention in human and animal healthcare and contamination control in industry.
The Investor Centre was last updated on 17/10/2018. The information contained within it is disclosed in accordance with AIM Rule 26. The Company is subject to the UK City Code on Takeovers and Mergers.
The Tristel story began in 1993 when the founding shareholders developed a proprietary chlorine dioxide formulation to be used for the disinfection of flexible endoscopes to replace glutaraldehyde. At the time, glutaraldehyde was used universally throughout hospitals in the United Kingdom, and indeed worldwide, for the disinfection of heat sensitive medical instruments. However, it was known to be toxic.
During the following decade Tristel captured significant market share in the United Kingdom hospital market. In June 2005 Tristel plc was listed on the London Stock Exchange AIM market.
By this time the Company had developed a broader vision for the use of its chlorine dioxide chemistry and had developed products for the disinfection of a wide range of non-lumened and single lumened endoscopes and ultrasound probes, and also the disinfection of surfaces in hospitals.
A key milestone in Tristel’s development was the establishment of its manufacturing plant in Cambridgeshire in 2007. The Company is an ISO 9001: 2008 and BS EN 13485:2003 accredited manufacturer of disinfectants.
Today, Tristel serves the disinfection requirements of veterinary practices via its Anistel product range and those of clean rooms in healthcare and the life sciences industry via its Crystel product range. The Company operates a Class 6 cleanroom to manufacture sterile-packed disinfectant products.
The Company has subsidiaries in Germany, Poland, Switzerland, Russia, Hong Kong, China, Australia, New Zealand, Japan and USA, an associated company in Italy, and sells its products via distributors in more than thirty other countries.